<?xml version="1.0" encoding="UTF-8"?>
<p>On the other hand, spirooxindoles 
 <bold>6a–c</bold>, 
 <bold>6e</bold>, 
 <bold>6f</bold>, 
 <bold>6i</bold>-
 <bold>k</bold> and 
 <bold>6 m</bold>, with dual activity against both here examined HepG2 and PC-3 cancer cell lines, were tested for their potential cytotoxic impact towards the non-tumorigenic human breast MCF-10A cell line in order to explore the safety profile of the target spirooxindole scaffold towards the normal cells, 
 <xref rid="t0002" ref-type="table">Table 2</xref>.
</p>
